Perrigo (PRGO) Could Be 12% Undervalued After Annual Results And A 30% Rally
Perrigo (PRGO) has drawn investor attention after its annual figures showed revenue of US$4.14b and a reported net loss of US$1.70b, alongside modest reported revenue growth and strong reported net income growth.
Perrigo’s share price has climbed 30.5% over the past 90 days and 13.6% across the last month, signalling improving short term momentum. However, the 1 year total shareholder return is still down 28.4%, pointing to a longer running period of weak results for investors.
Contrast Perrigo’s recent swing in momentum with other companies on our hand picked 49 high quality undervalued stocks that also pair balance sheet strength with what the market may be pricing cautiously.
Bulls see Perrigo’s rebound and net income growth as a reset, while bears point to the recent loss and longer term share price damage. Which side looks closer to fair value when you compare it with fundamentals?
Most Popular Narrative: 11.6% Undervalued
The most followed narrative pegs Perrigo’s fair value at $16.50, compared with the last close at $14.58, framing a valuation gap that rests on detailed long term assumptions.
The aging global population and rising consumer interest in self-care and wellness continue to create longer-term demand tailwinds for Perrigo's OTC and nutrition products, providing stable, defensive revenue streams even in periods of macro uncertainty.
Want to see what has to go right for that price to hold up? The narrative leans heavily on margin repair, steady top line, and a richer future earnings multiple. Curious which specific profit and discount rate assumptions carry most of the weight here?
Result: Fair Value of $16.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, Perrigo’s recent goodwill impairment charges and the risk of weaker demand in key OTC and infant nutrition categories could quickly challenge that upbeat fair value story.
Find out about the key risks to this Perrigo narrative.
Next Steps
Mixed on Perrigo after all that, or starting to form a clear opinion already? Act while the data is fresh in your mind, and pressure test your thesis against the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Perrigo?
Do not stop at Perrigo. Use fresh data to compare what you own with other opportunities, and let a structured screener sharpen where you focus next.
- Hunt for potential mispricings by scanning a curated 49 high quality undervalued stocks that combines quality fundamentals with cautious market expectations.
- Zero in on resilience by checking a list of solid balance sheet and fundamentals (24 results) so you can filter for businesses with stronger financial footing.
- Spot under-the-radar potential by reviewing a 17 high quality undiscovered gems that highlights companies the broader market may not be watching yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com